Related Experiment Video
Updated: Nov 27, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
High expression of microRNA 221 is a poor predictor for glioma
Yanlin Song1,2, Min He3, Jing Zhang1
1Department of Neurosurgery and National Clinical Research Center for Geriatrics.
Background:
MicroRNA 221 has been found to be a good marker for several cancers. Some studies also focused on the relationship between microRNA 221 and glioma. However, the results are controversial. We aimed to systematically evaluate the prognostic role of microRNA 221 in glioma through performing a meta-analysis.
Methods:
The articles which were included in our study were searched on the Web of Science, EMBASE, PubMed, Cochrane Library and China National Knowledge Infrastructure. The basic characteristics and relevant data were extracted. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled to evaluate the prognostic role of microRNA 221 in glioma.
Results:
Eight studies with 1069 patients were included. We systematically evaluated the role of microRNA 221 for overall survival (OS) and disease free survival (DFS) in glioma patients (HR for OS = 1.66, 95% CI, 1.34-2.04; HR for DFS = 1.14, 95% CI, 1.02-1.26). Subgroup analyses were performed according to the nation of the studies, the origin of the samples, the stage of the tumors, the cut-off value, and the method for detecting the microRNA 221. No significant publication bias was found (P = .133).
Conclusion:
In conclusion, high expression of microRNA 221 was related to poor prognosis of glioma. These findings may assist future exploration on microRNA 221 and help predict the prognosis of glioma. However, due to the significant heterogeneity of these studies, more studies are warranted.
Insights
High microRNA 221 expression indicates a poor prognosis for glioma patients. This meta-analysis confirms its role in predicting overall survival and disease-free survival, aiding future glioma research.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Research
Background:
- MicroRNA 221 (miR-221) is implicated as a potential biomarker in various cancers.
- Previous studies on miR-221's role in glioma prognosis have yielded conflicting results.
- A systematic evaluation is needed to clarify the prognostic significance of miR-221 in glioma.
Purpose of the Study:
- To conduct a meta-analysis systematically evaluating the prognostic role of microRNA 221 in glioma.
- To synthesize existing evidence regarding the association between miR-221 expression and patient outcomes in glioma.
Main Methods:
- Comprehensive literature search across major databases (PubMed, Web of Science, EMBASE, Cochrane Library, CNKI).
- Extraction of relevant data and characteristics from eligible studies.
- Pooled analysis of Hazard Ratios (HRs) with 95% Confidence Intervals (CIs) to assess prognostic value.
Main Results:
- Eight studies comprising 1069 glioma patients were included in the meta-analysis.
- Elevated miR-221 expression was significantly associated with poorer overall survival (HR = 1.66, 95% CI: 1.34-2.04).
- Increased miR-221 levels also correlated with reduced disease-free survival (HR = 1.14, 95% CI: 1.02-1.26).
Conclusions:
- High expression of microRNA 221 is linked to unfavorable prognosis in glioma patients.
- These findings support miR-221 as a potential predictive biomarker for glioma.
- Further research is recommended to address the heterogeneity observed across studies and solidify clinical application.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

